Etiket: Tilray
GNW-Adhoc: Tilray provides international cannabis update on the milestone of German cannabis legalization
^The release of cannabis in Germany opens up new opportunities for Tilray in the potential $3 billion medical products market Medical cannabis market in the European Union now stands at…
Tilray Stock: Market Leader in the Cannabis Sector & Beverage Diversification. Record sales are convincing!
The latest developments in the production, research and development of medical cannabis are published. This is because the company focuses on providing high-quality, standardized products for patients with various medical…
Outlook: Tilray (ex Aphria) publishes figures for the last quarter
Tilray (ex Aphria) has quarterly figures coming up. What analysts expect. Tilray (ex Aphria) will open the books for the previous quarter, which ended on November 30, 2023, in the…
Tilray stock: Tilray looking to buy HEXO amid consolidation in Canada’s cannabis market
shares in this article • Revenue growth and 16th consecutive quarter of positive Adjusted EBITDA • Further growth planned • Completed final agreement on HEXO purchase Tilray makes slightly more…
Why stock market expert Jim Cramer recommends buying cannabis giant Tilray
shares in this article • Cannabis stocks with a weak 2022 • Jim Cramer thinks Tilray is a buy • Strong positioning in the US market Tilray stock has lost…